Comparison of cilostazol and ticlopidine for one-month effectiveness and safety after elective coronary stenting

被引:17
作者
Hashiguchi, M
Ohno, K
Nakazawa, R
Kishino, S
Mochizuki, M
Shiga, T
机构
[1] Kitasato Univ, Sch Pharmaceut Sci, Ctr Clin Pharm & Clin Sci, Div Evaluat & Anal Drug Informat,Minato Ku, Tokyo 1088641, Japan
[2] Meiji Pharmaceut Univ, Dept Medicat Anal & Clin Res, Tokyo 2048588, Japan
[3] Tokyo Womens Med Univ, Dept Cardiol, Shinjuku Ku, Tokyo 1628666, Japan
关键词
cilostazol; ticlopidine; aspirin; oral antiplatelets; effectiveness; safety; coronary stenting; meta-analysis; one-month;
D O I
10.1023/B:CARD.0000033642.49162.04
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To compare the oral antiplatelets, phosphodiesterase III inhibitor cilostazol and the thienopyridine ticlopidine, for one-month effectiveness and safety as an adjunctive therapy after coronary stenting. Methods: Published studies retrieved through Medline and other databases from 1966 - 2002. Meta-analyses evaluated effectiveness and adverse side effects for one-month administrations of aspirin plus cilostazol or aspirin plus ticlopidine therapy after coronary stenting. Major adverse cardiac events (MACE), stent-associated thrombosis or adverse side effects after coronary stenting were compared between the two study arms and expressed with the odds ratios ( OR) specific for the individual studies and metaanalytic summary for OR. Results: Five clinical studies met the inclusion criteria, and 4 of these studies underwent meta-analysis. With regard to the comparison of the OR summary for MACE and stent-associated thrombosis for the clinical outcome, there were no statistical significant differences between aspirin plus cilostazol and aspirin plus ticlopidine. While, the incidence of adverse side effects tended to be lower, they were not statistically significant in patients with aspirin plus cilostazol. Conclusions: Our meta-analysis results indicated that there were no differences between cilostazol ( plus aspirin) and ticlopidine ( plus aspirin) with regard to effectiveness and safety for a one-month period when used as an adjunctive therapy after coronary stenting.
引用
收藏
页码:211 / 217
页数:7
相关论文
共 40 条
[21]   Clopidogrel as adjunctive antiplatelet therapy during coronary stenting [J].
Mishkel, GJ ;
Aguirre, FV ;
Ligon, RW ;
Rocha-Singh, KJ ;
Lucore, CL .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (07) :1884-1890
[22]  
MORIZANE T, 2002, EBM UPGRADE PHYSICAN
[23]   A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents [J].
Müller, C ;
Büttner, HJ ;
Petersen, J ;
Roskamm, H .
CIRCULATION, 2000, 101 (06) :590-593
[24]   CILOSTAZOL [J].
OKUDA, Y ;
KIMURA, Y ;
YAMASHITA, K .
CARDIOVASCULAR DRUG REVIEWS, 1993, 11 (04) :451-465
[25]   SYNERGISTIC INTERACTIONS BETWEEN SELECTIVE PHARMACOLOGICAL INHIBITORS OF PHOSPHODIESTERASE ISOZYME FAMILIES PDE-III AND PDE-IV TO ATTENUATE PROLIFERATION OF RAT VASCULAR SMOOTH-MUSCLE CELLS [J].
PAN, XL ;
ARAUZ, E ;
KRZANOWSKI, JJ ;
FITZPATRICK, DF ;
POLSON, JB .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (04) :827-835
[26]   Comparison of cilostazol versus ticlopidine therapy after stent implantation [J].
Park, SW ;
Lee, CW ;
Kim, HS ;
Lee, HJ ;
Park, HK ;
Hong, MK ;
Kim, JJ ;
Park, SJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (05) :511-514
[27]   Effects of cilostazol on angiographic restenosis after coronary stent placement [J].
Park, SW ;
Lee, CW ;
Kim, HS ;
Lee, NH ;
Nah, DY ;
Hong, MK ;
Kim, JJ ;
Park, SJ .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (05) :499-503
[28]   Platelet-active drugs - The relationships among dose, effectiveness, and side effects [J].
Patrono, C ;
Coller, B ;
Dalen, JE ;
FitzGerald, GA ;
Fuster, V ;
Gent, M ;
Hirsh, J ;
Roth, G .
CHEST, 2001, 119 (01) :39S-63S
[29]   Ticlopidine and clopidogrel [J].
Quinn, MJ ;
Fitzgerald, DJ .
CIRCULATION, 1999, 100 (15) :1667-1672
[30]   A COMPARISON OF BALLOON-EXPANDABLE-STENT IMPLANTATION WITH BALLOON ANGIOPLASTY IN PATIENTS WITH CORONARY-ARTERY DISEASE [J].
SERRUYS, PW ;
DEJAEGERE, P ;
KIEMENEIJ, F ;
MACAYA, C ;
RUTSCH, W ;
HEYNDRICKX, G ;
EMANUELSSON, H ;
MARCO, J ;
LEGRAND, V ;
MATERNE, P ;
BELARDI, J ;
SIGWART, U ;
COLOMBO, A ;
GOY, JJ ;
VANDENHEUVEL, P ;
DELCAN, J ;
MOREL, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (08) :489-495